Hepatitis B virus screening before adjuvant chemotherapy in patients with early stage breast cancer: A cost-effectiveness analysis.

Authors

null

William W. L. Wong

University of Toronto, Toronto, ON, Canada

William W. L. Wong , Lisa K. Hicks , Hong-Anh Tu , Murray Krahn , Kathleen I. Pritchard , Jordan J. Feld , Kelvin K. Chan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Health Services Research and Quality of Care

Track

Health Services Research and Quality of Care

Sub Track

Value/Cost of Care

Citation

J Clin Oncol 33, 2015 (suppl; abstr 6617)

DOI

10.1200/jco.2015.33.15_suppl.6617

Abstract #

6617

Poster Bd #

174

Abstract Disclosures

Similar Posters

Poster

2011 ASCO Annual Meeting

Screening for hepatitis B virus (HBV) prior to chemotherapy: A cost-effectiveness analysis.

Screening for hepatitis B virus (HBV) prior to chemotherapy: A cost-effectiveness analysis.

First Author: U. Zurawska

First Author: F. L. Day

Poster

2024 ASCO Annual Meeting

Predicting completion of endocrine therapy for older patients with early-stage breast cancer.

Predicting completion of endocrine therapy for older patients with early-stage breast cancer.

First Author: Jerome Karp

Poster

2023 ASCO Annual Meeting

Clinical validation of an activity-based enzyme assay for early stage lung cancer.

Clinical validation of an activity-based enzyme assay for early stage lung cancer.

First Author: Paul W. Dempsey